EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients

Omayma A Kishk iD, Ivone Kim iD, Carmen Cheng iD, Mukesh Summan, Monica A Muñoz iD

Pediatric Nephrology · 2024

DOI: 10.1007/s00467-024-06339-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Nephrology, 2024. Verfasst von Omayma A Kishk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacovigilance, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 1…. Hauptthemen laut MEDLINE: Cysteamine, Cystinosis, Delayed-Action Preparations. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The objective of this report is to identify and characterize cases of fibrosing colonopathy, a rare and underrecognized adverse event, associated with cysteamine delayed-release (DR) in patients with nephropathic cystinosis.

Methods

We searched the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) and the medical literature for postmarketing reports of fibrosing colonopathy associated with cysteamine through August 2, 2023.

Results

We identified four cases of fibrosing colonopathy reported with the use of cysteamine DR. The time to onset ranged from 12 to 31 months. In one case, the patient required surgery to have a resection of a section of the strictured colon and a diverting ileostomy. Fibrosing colonopathy was diagnosed by histopathology in two of the cases.

Conclusions

Our case series identified the risk of fibrosing colonopathy in patients taking cysteamine DR and prompted regulatory action by the FDA. As outlined in changes to the U.S. prescribing information for cysteamine DR, healthcare professionals should be aware of the potential risk of fibrosing colonopathy with cysteamine DR, especially as symptoms can be non-specific leading to misdiagnosis or delayed diagnosis. If the diagnosis of fibrosing colonopathy is confirmed, consideration should be given to permanently discontinuing cysteamine DR and switching to cysteamine immediate-release treatment. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CysteamineCystinosisDelayed-Action PreparationsAdolescentChildChild, PreschoolFemaleHumansMaleAdverse Drug Reaction Reporting SystemsCapsulesColonColonic DiseasesCystine Depleting AgentsFibrosisUnited States

Stichwörter der Autor:innen

Adverse eventCysteamine delayed-releaseCystinosisFibrosing colonopathyPharmacovigilance

Substanzen

CapsulesCysteamineCystine Depleting AgentsDelayed-Action Preparations

Autor:innen und Institutionen

  • Division of Pharmacovigilance, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA. omayma.kishk@fd…
  • Division of Pharmacovigilance, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA.
  • Division of Pharmacology and Toxicology, Rare Diseases, Pediatrics, Urologic and Reproductive Medicine, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshir…

ORCID-Profile: Omayma A Kishk, Ivone Kim, Carmen Cheng, Monica A Muñoz

Zitieren

APA

Kishk, O. A., Kim, I., Cheng, C., Summan, M., & Muñoz, M. A. (2024). Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients. Pediatric Nephrology. https://doi.org/10.1007/s00467-024-06339-z

Vancouver

Kishk OA, Kim I, Cheng C, Summan M, Muñoz MA. Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients. Pediatric Nephrology. 2024. doi:10.1007/s00467-024-06339-z

BibTeX
@article{Kishk2024,
  author = {Kishk, Omayma A and Kim, Ivone and Cheng, Carmen and Summan, Mukesh and Muñoz, Monica A},
  title = {Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients},
  journal = {Pediatric Nephrology},
  year = {2024},
  doi = {10.1007/s00467-024-06339-z}
}
Kostenlos starten →